Canine aggression remains a leading cause of injuries to people and pets, and it drives many owners to surrender dogs to shelters.
Hormone Levels Linked to Aggressive Behavior
Researchers from the University of Arizona examined the roles of two neuropeptides—oxytocin and vasopressin—in dogs that display leash‑aggressive tendencies. The study, published in Frontiers in Psychology, each animal was leashed by its owner while a recorded bark played behind a curtain. When the curtain opened, a life‑size dog model accompanied by a human was revealed.
Most aggressive dogs responded with growls, barks, and lunges, whereas the control group stayed calm. Blood samples taken before and after the exposure showed that the aggressive dogs had a marked increase in vasopressin, a hormone associated with aggression in humans. Oxytocin levels, by contrast, stayed roughly the same across both groups.
Related: Is Lemon Safe for Dogs and Cats
To provide context, the investigators also measured oxytocin in a separate cohort of assistance dogs, which are selectively bred for friendly, non‑aggressive temperaments. Those dogs exhibited higher oxytocin concentrations than the study dogs.
Implications for Managing Aggression
Past approaches to reducing dog aggression have emphasized neutering to lower testosterone and prescribing serotonin‑enhancing drugs. The new findings suggest that targeting vasopressin and oxytocin could offer alternative pathways.
One reason vasopressin may rise in aggressive dogs is exposure to traumatic events. Owners often report that aggression began after a dog was attacked or otherwise threatened, leading to a heightened state of vigilance that resembles post‑traumatic stress. This aligns with the broader view that life experiences can reshape hormone function.
Related: As Dogs Age So Should Their Food
These hormone patterns reveal how biology and environment intertwine in shaping a dog’s social responses. Understanding that aggression may stem from a hormonal imbalance rather than solely from training deficits can shift how owners and professionals approach treatment, encouraging a combination of behavior modification and targeted biochemical support.
The research team called for future work to explore whether therapies that modulate these neuropeptides improve outcomes for aggressive dogs.
If successful, such strategies could reduce the number of bites and relinquishments, preserving the long‑standing bond between humans and their canine companions.
